Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Nootropics Stories

2012-12-05 20:20:50

HOLLYWOOD, Fla., Dec. 5, 2012 /PRNewswire/ -- New study findings presented today showed a significantly lower mortality rate in patients who were treated with galantamine, a prescription medicine for mild to moderately severe Alzheimer's disease, versus those who received placebo. Patients treated with galantamine also had significantly lesser decline in cognitive impairment after two years, compared to patients in the placebo group, according to investigators presenting the data at the...

2012-12-05 08:27:14

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- Magnum Vita Inc, an innovator of specialized health supplements, is giving away 2,000 bottles of Mind Focux brain supplement in response to recent cheating scandals in New York schools. Secret To Success The made in USA Mind Focux brain supplement has only been found in select Asian pharmacies for $49.99 a bottle by thousands of grateful Asian students and their parents. The president of Magnum Vita Inc. has authorized 2,000 bottles of the...

2012-11-28 22:47:02

Medication development efforts for cocaine dependence have yet to result in an FDA approved treatment. The powerful rewarding effects of cocaine, the profound disruptive impact of cocaine dependence on one's lifestyle, and the tendency of cocaine to attract people who make poor life choices and then exacerbate impulsive behavior all make cocaine a vexing clinical condition. In this battle, many candidate pharmacotherapies have been tested, but none have succeeded sufficiently to be adopted...

ADHD Medication Lowers Crime
2012-11-23 05:10:50

Connie K. Ho for redOrbit.com — Your Universe Online A study by British and Swedish researchers recently found that medication for attention deficit-hyperactivity disorder (ADHD) could help reduce some instances of criminal behavior. Medications like Adderall, Ritalin, and other drugs could help limit hyperactivity and elevate the ability to focus. Reuters reports that Ritalin is produced by Novartis, a Swedish drug maker, while companies sell other ADHD drugs like Eli Lilly...

Studying The Influence Of ADHD Medications
2012-11-10 11:07:55

redOrbit Staff & Wire Reports — Your Universe Online Some drugs used to treat ADHD could affect the brain's reward system, researchers from the University of Copenhagen have discovered. The findings make it easier to understand how the medicine works and could ultimately lead to improvements in the development of and the dose determination associated with ADHD treatments, they report in the latest edition of the Journal of Neurophysiology. As part of the study, Jakob Kisbye...

2012-07-25 02:30:39

HUNTSVILLE, Ala., July 25, 2012 /PRNewswire-FirstCall/ -- Qualitest Pharmaceuticals today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam extended-release tablets, 500mg and 750mg, the generic equivalent of UCB's Keppra XR®. The total combined sales for Levetiracetam extended-release tablets, 500mg and 750mg, in the U.S. for the 12 months ending May 31, 2012, were...

2012-07-12 23:02:47

Methylphenidate prescriptions have increased fourfold in the last decade, and yet estimates as to its effectiveness suggest a sizeable 'gap' where children do not respond to such drug-based treatment. A recent double-blind pilot trial shows a potential natural treatment breakthrough that may help fill this gap for children resistant to medication. Cambridge, UK (PRWEB) July 12, 2012 Recently published clinical research shows a potential ADHD treatment breakthrough using a pure EPA natural...

2012-06-25 10:25:35

SALT LAKE CITY, June 25, 2012 /PRNewswire/ -- Healthy, middle-aged women taking supplements of citicoline, a naturally occurring brain health nutrient, saw improved attention, focus and recall, according to a peer-reviewed study conducted by University of Utah scientists. The study was published Wednesday in Food and Nutrition Sciences. The double blind, placebo-controlled study composed of 60 healthy women between 40 and 60 years of age. After 28 days of citicoline administration, the study...

2012-06-23 06:20:16

PHILADELPHIA, June 23, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that on June 22, 2012, the US Food and Drug Administration (FDA) responded to Shire's Adderall XR citizen petition. The FDA's response requires that all abbreviated new drug applications (ANDAs) have to establish bioequivalence using partial area under the curve measurements at 5 hours and beyond 5 hours, for both d- and l- amphetamine. The...

2012-06-08 02:23:36

PITTSBURGH, June 8, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has resolved all disputes with Teva Pharmaceuticals USA, Inc. stemming from litigation brought by Mylan in federal court in the District of Columbia against the U.S. Food and Drug Administration (FDA) concerning Mylan's abbreviated new drug application (ANDA) for Modafinil Tablets, 100 mg and 200 mg. Modafinil Tablets are the generic version of Cephalon's...